Clinical Trial Update: Standard Post Market Clinical Follow-up (PMCF) Study WSA 2025 [NA]

View source ↗

Summary

The PMCF study WSA 2025 for sensorineural hearing loss has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hearing Loss Sensorineural

Snippet

Sponsor: WSAUD A/S | Conditions: Hearing Loss, Sensorineural | NA | Status: COMPLETED